Skip to main content

Huge Growth on Nuclear Medicine/Radiopharmaceuticals Market by 2027: Growing Popularity and Emerging Trends in the Market | Cardinal Health, IBA Worldwide, Curium, Bayer

Press release   •   Oct 03, 2019 23:03 IST

Nuclear Medicine/Radiopharmaceuticals Market

The market for nuclear medicine/radiopharmaceuticals is expected to grow, owing to factors such as rising prevalence of chronic diseases, alpha radioimmunotherapy-based targeted oncology treatment and advancement in imaging technologies using radiopharmaceuticals play vital role in the growth of the radiopharmaceuticals market. However, the restraints such as short shelf-life of radiopharmaceuticals and availability of substitutes of radiopharmaceuticals are likely to impact the growth of the market in the forecast period.

Worldwide Nuclear Medicine/Radiopharmaceuticals Market Analysis to 2027 is a specialized and in-depth study of the Nuclear Medicine/Radiopharmaceuticals industry with a focus on the global market trend. The report aims to provide an overview of global Nuclear Medicine/Radiopharmaceuticals market with detailed market segmentation by product & services /application and geography. The global Nuclear Medicine/Radiopharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Nuclear Medicine/Radiopharmaceuticals players and offers key trends and opportunities in the market.

Get Sample Copy of this Report at – https://www.theinsightpartners.com/sample/TIPRE00003751/

Some of the prominent players operating in Nuclear Medicine/Radiopharmaceuticals market are:-

Cardinal Health, IBA Worldwide, Curium, GENERAL ELECTRIC, Bayer AG, Positron Corporation, NTP Radioisotopes SOC Ltd, Bracco, Lantheus Medical Imaging Inc., and Advanced Accelerator Applications

An exclusive Nuclear Medicine/Radiopharmaceuticals market research report created through broad primary research (inputs from industry experts, companies and stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine/Radiopharmaceuticals Market By Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Nuclear Medicine/Radiopharmaceuticals market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Global nuclear medicine/radiopharmaceuticals market, based on the applications, was segmented as, diagnostic applications and therapeutic applications. In 2018, the diagnostic applications segment held a largest market share of 70.6% of the radiopharmaceuticals market, by applications. This segment is also expected to dominate the market in 2027 owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders. Moreover, increasing incidences of cardiac diseases, cancer, and neurological disorders are expected to fuel the demand for better diagnosis of these disorders. Also, nuclear medicine provide better diagnostic information about the functioning of a specific organ, as it uses radiation. Hence, owing to the above statements, this segment is also anticipated to witness the growth at a significant rate during the forecast period, 2019 to 2027.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Nuclear Medicine/Radiopharmaceuticals market based on product and application. It also provides market size and forecast till 2027 for overall Nuclear Medicine/Radiopharmaceuticals market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Diagnostic applications segment is expected to grow the market for nuclear medicine/radiopharmaceuticals over the forecast period for applications segment.

Inquire about this Report at - https://www.theinsightpartners.com/inquiry/TIPRE00003751/

Also, key Nuclear Medicine/Radiopharmaceuticals market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. 

Key Benefits of Buying this Research Study:


  1. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Nuclear Medicine/Radiopharmaceuticals Market
  2. Highlights key business priorities in order to assist companies to realign their business strategies
  3. The key findings and recommendations highlight crucial progressive industry trends in the Nuclear Medicine/Radiopharmaceuticals Market, thereby allowing players across the value chain to develop effective long term strategies
  4. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  5. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
  6. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
  7. Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.

About Us: 

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us: Call: +1-646-491-9876
Email: sales@theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.